Progress, Potential, and Possibilities Podcast By Ira Pastor cover art

Progress, Potential, and Possibilities

Progress, Potential, and Possibilities

By: Ira Pastor
Listen for free

Interviews and Discussions With Fascinating People Who are Creating A Better Tomorrow For All Of Us Host - Ira S. Pastor© 2023 Progress, Potential, and Possibilities Hygiene & Healthy Living Science
Episodes
  • Dr. Lara Nyman, Ph.D. - VP, Research & Discovery, AG1 - Clinically Backed Foundational Nutrition
    Jul 22 2025

    Send us a text

    Dr. Lara Nyman, Ph.D. is the Vice President of Research & Discovery at AG1 ( https://drinkag1.com/learn/research/scientific-research ), responsible for leading the company's innovative research efforts to develop cutting-edge nutritional products. In this role, she oversees the research and development of new formulations, ensures the scientific integrity of product claims, and collaborates with cross-functional teams to drive product innovation.

    Dr. Nyman previously served as the Chief Scientific Officer at Weo, a water augmentation company, providing strategic guidance and scientific oversight to the company's product development and research initiatives, working closely with their R&D team to identify emerging trends, evaluate new technologies, and translate scientific insights into compelling consumer offerings.

    Prior to Weo, Dr. Nyman served as Senior Principal Scientist in the Claims Center of Excellence for Consumer Health & Wellness at PepsiCo, leveraging her deep understanding of consumer needs and scientific principles to develop innovative, evidence-based claims for the company's health and wellness products.

    Dr. Nyman holds a Master of Science (MS) in Exercise Physiology from Southern Connecticut State University, a Ph.D. in Cellular and Molecular Physiology from University of Alabama at Birmingham, and was a Post-Doctoral Fellow, Department of Medicine, Division of Diabetes, Endocrinology, and Metabolism at Vanderbilt University School of Medicine.

    #LaraNyman #AG1 #AthleticGreens #ExercisePhysiology #Endocrinology #Metabolism #FoundationalNutrition #Wellness #NutrientGaps #NutrientSynergy #Nutrigenomics #Synbiotics #Microbiome #WholeFood #Superfoods #Probiotics #Adaptogens #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #Research

    Support the show

    Show more Show less
    33 mins
  • Pedro Sanchez de Lozada - CEO, Canid - Streamlining Pediatric Vaccine Management
    Jul 19 2025

    Send us a text

    Pedro Sanchez de Lozada is Co-Founder and CEO of Canid ( https://www.canid.io/ ), a company which is modernizing every aspect of providing vaccines in pediatrics, from operations, to finances, to maximizing care. Canid focuses the details of executing a vaccine program so that pediatricians can instead focus on the children.

    Pedro is a seasoned CEO with a background in early-stage startup development, operations, and marketing at prominent venture-backed companies, including roles as: Director Of Marketing at Merlin, Head of Launch in Washington DC at Rinse, Growth Engineer at Koding, Business Development and Marketing professional at Udemy, and Vice-president of Marketing at Road to Innovative Social Entrepreneurship.

    Pedro has also served as a Curator at TEDxUChicago, Founder of LogiMD, and was a Fellow at On Deck.

    Pedro has a Bachelor of Arts in Economics from the University of Chicago.

    #PedroSanchezDeLozada #Canid #Vaccines #Vaccination #Pediatrics #VaccineAcquisitionCosts #ReimbursementRates #Overhead #InventoryManagement #ImmunizationInformationSystems #StateImmunizationRegistries #AdvisoryCommitteeOnImmunizationPractices #ACIP #PatientEligibility #Procurement #Pediatricians #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #Research

    Support the show

    Show more Show less
    50 mins
  • Dr. Marc Salzberg, MD - CEO, Airway Therapeutics - Novel Biologics For Severe Respiratory Diseases
    Jul 17 2025

    Send us a text

    Dr. Marc Salzberg, MD is President, Chief Executive Officer & Chief Medical Officer of Airway Therapeutics ( https://www.airwaytherapeutics.com/ ), a biopharmaceutical company developing a new class of biologics to break the cycle of injury and inflammation for patients with respiratory and inflammatory diseases.

    Dr. Salzberg has more than 25 years of academic and pharmaceutical experience in the management of drug development and clinical research, including medical management of anti-viral drugs clinical development and market introduction including saquinavir and ganciclovir. He spent several years at Roche’s headquarters in Basel, Switzerland as well as its affiliate in Toronto, Canada. As Head of Clinical Cancer Research at the Basel University, he co-founded and managed a clinical research network in Switzerland (CCRC).

    During his career, Dr. Salzberg has successfully managed the growth and acquisition of two contract research organizations benefitting shareholders. He was a founder and President of Pharma Brains, a European boutique CRO, which has been acquired by Medpace, a US based global CRO, after 10 years of successful growth under his leadership. He then served as Vice President of Medical Affairs at Medpace.

    Dr. Salzberg earned his Medical Doctorate degree from the University of Basel, Switzerland. His medical training and practice include pediatrics/ neonatology and oncology.

    #MarcSalzberg #AirwayTherapeutics #HumanSurfactantProteinD #Collectin #PathogenRecognition #RespiratoryDiseases #InflammatoryResponse #BronchopulmonaryDysplasia #ZelpultideAlfa #Covid #Asthma #COPD #Influenza #RSV #ARDS #AcuteRespiratoryDistressSyndrome #ChronicObstructivePulmonaryDisease #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #Research

    Support the show

    Show more Show less
    39 mins
No reviews yet